Log in to search using one of your social media accounts:

This page shows you the latest items in this publication.

Smaller Babies for Women With, and After, Cancer Smaller Babies for Women With, and After, Cancer
Women who have cancer as adolescents or young adults have an increased risk for preterm birth and low birthweight, and the risk is greatest when care is diagnosed during pregnancy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 24, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Mutations Mostly Due to ' Bad Luck ' -- New Data Cancer Mutations Mostly Due to ' Bad Luck ' -- New Data
A new article reiterates findings from 2 years ago that cancer mutations are indeed mostly the result of ' bad luck. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 24, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Avelumab: First Drug Ever Approved for Merkel Cell Carcinoma Avelumab: First Drug Ever Approved for Merkel Cell Carcinoma
Patients who develop this rare but aggressive skin cancer have not had a specific therapy, until today ' s approval of a novel immunotherapy.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Rucaparib ' Very Active ' for High-Grade Ovarian Cancer Rucaparib ' Very Active ' for High-Grade Ovarian Cancer
Dr Maurie Markman reports on high response rates to rucaparib therapy for ovarian cancer and looks forward to future research efforts using this PARP inhibitor.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

State of Cancer Care in US: ' Far From Adequate ' State of Cancer Care in US: ' Far From Adequate '
The fourth annual report on the state of cancer care in America delivers a mixed picture of how cancer care is delivered and to whom across the US.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Reduce Cancer Care Costs by Avoiding ' Low-Value ' Options Reduce Cancer Care Costs by Avoiding ' Low-Value ' Options
Oncologists can help reduce the cost of treating cancer by avoiding ' low-value ' oncology choices and favoring drug regimens with proven benefits and lower costs.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Update on Rare Breast Implant-Associated Type of Lymphoma FDA Update on Rare Breast Implant-Associated Type of Lymphoma
The FDA says breast implant-associated anaplastic large cell lymphoma is a rare T cell lymphoma that can develop after breast implants and provides guidance for clinicians.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2017 Category: Cancer & Oncology Tags: Plastic Surgery & Aesthetic Medicine News Alert Source Type: news

Turbulent Reign Over: Top Exec at Top Cancer Center Resigns Turbulent Reign Over: Top Exec at Top Cancer Center Resigns
MD Anderson ' s embattled president, Ronald DePinho, is leaving the top job, leaving behind a controversial legacy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Why the High CRC Rate in Latino--Genes, Stigma, or Other Factors? Why the High CRC Rate in Latino--Genes, Stigma, or Other Factors?
Colorectal cancer is the second most common cause of cancer death in the Latino population. Drs John Marshall and Marcia Cruz-Correa discuss which factors are at play.Ruesch Center (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

CTCs Detect Lung Cancer Recurrence 6 Months Before Scans CTCs Detect Lung Cancer Recurrence 6 Months Before Scans
Circulating tumor cells were able to detect disease recurrence an average of 6 months before standard imaging.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Prostate Cancer and Vasectomy Not Linked … But With One Caveat Prostate Cancer and Vasectomy Not Linked … But With One Caveat
A new large study found no association between prostate cancer and vasectomy, except for a small increase in the risk for low-intermediate-grade disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 16, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Start Palliative Care at Diagnosis for Kids With Cancer Start Palliative Care at Diagnosis for Kids With Cancer
Palliative care should be started early for children with cancer, ideally at the time they are diagnosed, experts say.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 16, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Metastases, Not Death, New Benchmark in Prostate Cancer? Metastases, Not Death, New Benchmark in Prostate Cancer?
Prostate cancer experts argue in favor of changing the primary endpoint of active surveillance trials to metastatic disease to reflect what is clinically meaningful to men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 16, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO Guidelines on Adjuvant Bisphosphonates in Breast Cancer ASCO Guidelines on Adjuvant Bisphosphonates in Breast Cancer
Because adjuvant bisphosphonate has shown a survival benefit, clinicians should consider using it in postmenopausal early breast cancer, say the new guidelines.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Safe Way to Save $164 Million a Year in Breast Cancer Safe Way to Save $164 Million a Year in Breast Cancer
If practitioners subscribed to evidence-based radiation therapy for women aged 50 years or older with early-stage breast cancer, the United States healthcare system could save a lot of money.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Chemoradiation Boosts Survival in Elderly Glioblastoma Patients Chemoradiation Boosts Survival in Elderly Glioblastoma Patients
Adding temozolomide to radiotherapy improves survival in elderly glioblastoma patients when compared to radiotherapy alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs Pembrolizumab for Classical Hodgkin Lymphoma FDA OKs Pembrolizumab for Classical Hodgkin Lymphoma
FDA approval was based on tumor response rate and durability of response. Continued approval may hinge on clinical benefits verified and described in confirmatory trials.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Olaparib Maintenance Therapy Boosts PFS in Ovarian Cancer Olaparib Maintenance Therapy Boosts PFS in Ovarian Cancer
Maintenance treatment with olaparib significantly increased progression-free survival in patients with germline BRCA-mutated ovarian cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Acupuncture Reduces Two Types of Cancer Pain Acupuncture Reduces Two Types of Cancer Pain
The largest study of its kind found that the Chinese medicine is effective only for the treatment of two kinds of pain; some US experts disagreed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Case Presentation or Single-Patient Trial? Case Presentation or Single-Patient Trial?
Dr David Kerr views a case of engineered T cells in a CRC patient with pulmonary metastases as an example of a single-patient clinical trial, neatly illustrating the potential of precision medicine.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 13, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

SRS for Brain Mets: How Many Lesions Can It Safely Treat? SRS for Brain Mets: How Many Lesions Can It Safely Treat?
There appears to be no consensus on the optimal treatment strategy for more than three lesions, and guidelines to help in decision making are lacking.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 10, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Imatinib Changed Everything ' : The Future Is Now More Hopeful ' Imatinib Changed Everything ' : The Future Is Now More Hopeful
The development in the 1990s of this oral drug that targets a driver mutation ' fundamentally altered the field of oncology, ' says an NEJM editorial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Known Cancer Prevention Strategies Must Be Implemented Known Cancer Prevention Strategies Must Be Implemented
Public health experts call for increased efforts to prevent cancer by using known cancer prevention strategies, including vaccination against HPV, lifestyle changes, and screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Muscle Composition Metric May Help Predict Chemo Toxicity Muscle Composition Metric May Help Predict Chemo Toxicity
An experimental metric that measures muscle composition may be able to predict which patients are most likely to experience chemotherapy-related side effects.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Neurofeedback Promising in Chemotherapy-Induced Neuropathy Neurofeedback Promising in Chemotherapy-Induced Neuropathy
Neurofeedback attenuates pain and unpleasantness of chemotherapy-induced peripheral neuropathy compared with usual care, and has virtually no side effects.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 7, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Eating Soy Tied to Reduced Breast Cancer Death Risk Eating Soy Tied to Reduced Breast Cancer Death Risk
Intake of soy food products, such as tofu, is not harmful for women with breast cancer and may be protective in those with hormone receptor-negative disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

The Puzzling Prognostic Effect of LDH in Melanoma The Puzzling Prognostic Effect of LDH in Melanoma
Although LDH is a negative prognostic factor in melanoma, patients who receive checkpoint inhibitors may still have responses of long duration even when their LDH level is high.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Juno Permanently Halts CAR T-Cell Study Juno Permanently Halts CAR T-Cell Study
After five patient deaths and other issues cited by the company, Juno has given up development of the chimeric antigen receptor (CAR) product JCAR015.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 3, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer-Related Fatigue: Exercise and Psych Therapy Best Cancer-Related Fatigue: Exercise and Psych Therapy Best
Both exercise and psychological interventions, used alone or in combination, were better than pharmaceuticals in relieving fatigue.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Coaching Program Gives Cancer Patients a VOICE in Their Care Coaching Program Gives Cancer Patients a VOICE in Their Care
Training oncologists to better their communication skills with patients and coaching patients to ask the right questions can improve patient-centered communication.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Universal Cancer Vaccine -- Still a Pipe Dream? Universal Cancer Vaccine -- Still a Pipe Dream?
A broad vaccine targeting many different tumors has been a ' holy grail ' of cancer therapy, but the seemingly limitless genetic diversity of cancer means it is unlikely, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 1, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Dramatic Rise in Colorectal Cancer in Younger Adults Dramatic Rise in Colorectal Cancer in Younger Adults
Colorectal cancer rates have risen dramatically among Generation Xers and millenials; researcher warns that repeal of the Affordable Care Act is ' very concerning ' for cancer diagnosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Important Milestone ' in Anal Cancer -- Later Assessment ' Important Milestone ' in Anal Cancer -- Later Assessment
Clinical guidelines for anal cancer may need to be revisited to allow for a longer period between chemoradiotherapy and assessment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Academia and Generics: Can They Reduce Cancer Drug Costs? Academia and Generics: Can They Reduce Cancer Drug Costs?
Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Hormone Therapy Prolongs PFS in Low-grade Serous Cancer Hormone Therapy Prolongs PFS in Low-grade Serous Cancer
Hormone maintenance therapy prolongs progression-free survival, if not overall survival, in low-grade serous carcinoma following surgery and chemotherapy compared with routine observation alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EU Panel Likes Novel Targeted Lung Cancer Combo EU Panel Likes Novel Targeted Lung Cancer Combo
The European panel has recommended for approval a targeted therapy combination for lung cancer with BRAF mutations and a treatment for chemotherapy-induced nausea and vomiting.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

A Blood Test for Breast Cancer: What Will It Tell Us? A Blood Test for Breast Cancer: What Will It Tell Us?
A preliminary report suggests that diagnosing breast cancer noninvasively may be possible using a blood sample. However, it is currently not ready for clinical practice.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Recurrent Colon Cancer: Location, Location, Location Recurrent Colon Cancer: Location, Location, Location
Tumor location, whether on the right or left side of the colon, seems to affect the prognosis and aggressiveness of recurrent colorectal cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Lenalidomide Approved for Myeloma Maintenance After HSCT Lenalidomide Approved for Myeloma Maintenance After HSCT
Lenalidomide (Revlimid) gets the first-ever FDA approval for use in myeloma as a maintenance therapy after autologous stem cell transplant.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Third of Oncologists Report High Burnout; 30% Turn to Alcohol Third of Oncologists Report High Burnout; 30% Turn to Alcohol
A meta-analysis of data from 4876 oncologists found that a third reported high burnout, or emotional exhaustion, and 30% reported drinking alcohol in a problematic way.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Costs Drive Prescription Changes in Cancer Survivors Costs Drive Prescription Changes in Cancer Survivors
Financial concerns are a major reason why cancer survivors change their prescription drugs, and why they do so at a higher rate than the general population.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 22, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Tattoos Help Breast Cancer Patients Heal After Mastectomy Tattoos Help Breast Cancer Patients Heal After Mastectomy
Artist David Allen empowers women who have had their breasts removed to feel a sense of control over their lives by drawing beautiful images over their mastectomy scars.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 21, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASTRO Guideline Update on Palliative Radiation for Bone Mets ASTRO Guideline Update on Palliative Radiation for Bone Mets
The updated guidelines continue to recommend four dosing schedules for palliative radiation, but some experts question whether more weight should be given to the single-dose option.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 21, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Fatal Neutropenic Enterocolitis With Docetaxel in France Fatal Neutropenic Enterocolitis With Docetaxel in France
Five fatal cases of neutropenic enterocolitis associated with a generic version of docetaxel have led one cancer centre to swap the drug for paclitaxel.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 20, 2017 Category: Cancer & Oncology Tags: Internal Medicine News Source Type: news

' Chemofog ' Persists in Many After Breast Cancer Treatment ' Chemofog ' Persists in Many After Breast Cancer Treatment
One of the largest studies to be conducted to date in a nationwide setting validates ' chemofog ' as a real problem, say authors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

In Sunny LA, Prostate Cancer Patients Just Walk Away In Sunny LA, Prostate Cancer Patients Just Walk Away
In a rare real-world study of adherence to active surveillance in Los Angeles, the percentage of men who are lost to follow-up is high, especially among poor patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Take With Food, Cut $9000 Prostate Cancer Pill Cost by 75% Take With Food, Cut $9000 Prostate Cancer Pill Cost by 75%
As with so many newer cancer drugs, abiraterone, for advanced castration-resistant prostate cancer, is very expensive. Here ' s a tip that may reduce cost greatly and does not appear to hurt efficacy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 17, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Questions Over Adjuvant Ipilimumab in Melanoma Questions Over Adjuvant Ipilimumab in Melanoma
An editorial raises questions on data for patient-reported outcomes for adjuvant ipilimumab, 10 mg/kg, in melanoma; toxicity also questioned.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 16, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Epigenetic Changes in Sperm Found 10 Years After Chemo Epigenetic Changes in Sperm Found 10 Years After Chemo
The new finding suggest that young men who undergo chemotherapy may have lasting genetic changes in their sperm that could be passed on to the next generation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 16, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Humorous Sun Safety Campaign Aims to ' Help a Dane ' Abroad Humorous Sun Safety Campaign Aims to ' Help a Dane ' Abroad
A humorous and innovative campaign to remind Danes to follow sun safety advice while abroad by asking the locals for help has been launched by sun safety campaigners across five countries.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 16, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news